Us Bancorp \De\ Astrazeneca PLC Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Astrazeneca PLC stock. As of the latest transaction made, Us Bancorp \De\ holds 232,419 shares of AZN stock, worth $15.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

232,419

Previous 217,454 6.88%

Holding current value

$15.4 Million

Previous $17 Million 6.79%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$76.67 - $87.62 $1.15 Million - $1.31 Million	14,965 Added 6.88%	232,419 $18.1 Million
Q2 2024 Aug 06, 2024	BUY	$66.81 - $80.83 $1.58 Million - $1.91 Million	23,595 Added 12.17%	217,454 $17 Million
Q1 2024 May 07, 2024	BUY	$61.03 - $69.57 $441,246 - $502,991	7,230 Added 3.87%	193,859 $13.1 Million
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $1.93 Million - $2.17 Million	31,252 Added 20.11%	186,629 $12.6 Million
Q3 2023 Nov 03, 2023	BUY	$64.85 - $71.7 $928,911 - $1.03 Million	14,324 Added 10.16%	155,377 $10.5 Million
Q2 2023 Aug 09, 2023	SELL	$69.91 - $75.81 $28,733 - $31,157	-411 Reduced 0.29%	141,053 $10.1 Million
Q1 2023 May 09, 2023	BUY	$63.15 - $71.6 $1.81 Million - $2.06 Million	28,706 Added 25.46%	141,464 $9.82 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $467,886 - $607,967	-8,631 Reduced 7.11%	112,758 $7.64 Million
Q3 2022 Oct 27, 2022	SELL	$53.02 - $135.75 $354,226 - $906,945	-6,681 Reduced 5.22%	121,389 $6.66 Million
Q2 2022 Aug 01, 2022	BUY	$59.26 - $71.14 $671,830 - $806,514	11,337 Added 9.71%	128,070 $8.46 Million
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $884,276 - $1.07 Million	15,870 Added 15.73%	116,733 $7.75 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $48,347 - $57,127	-895 Reduced 0.88%	100,863 $5.88 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $1.52 Million - $1.67 Million	27,444 Added 36.93%	101,758 $6.11 Million
Q2 2021 Aug 05, 2021	BUY	$48.42 - $60.18 $158,527 - $197,029	3,274 Added 4.61%	74,314 $4.45 Million
Q1 2021 Apr 28, 2021	SELL	$47.16 - $54.44 $271,830 - $313,792	-5,764 Reduced 7.5%	71,040 $3.53 Million
Q4 2020 Feb 04, 2021	BUY	$48.52 - $58.02 $186,316 - $222,796	3,840 Added 5.26%	76,804 $3.84 Million
Q3 2020 Nov 10, 2020	SELL	$53.07 - $61.1 $682,904 - $786,234	-12,868 Reduced 14.99%	72,964 $4 Million
Q2 2020 Aug 07, 2020	SELL	$43.1 - $55.31 $59,090 - $75,830	-1,371 Reduced 1.57%	85,832 $4.54 Million
Q1 2020 May 13, 2020	BUY	$37.79 - $51.33 $16,249 - $22,071	430 Added 0.5%	87,203 $3.89 Million
Q4 2019 Feb 04, 2020	SELL	$42.46 - $50.46 $22,885 - $27,197	-539 Reduced 0.62%	86,773 $4.33 Million
Q3 2019 Nov 08, 2019	BUY	$40.12 - $45.47 $1.28 Million - $1.45 Million	31,823 Added 57.35%	87,312 $3.89 Million
Q2 2019 Aug 13, 2019	BUY	$37.28 - $41.68 $142,596 - $159,426	3,825 Added 7.4%	55,489 $2.29 Million
Q1 2019 May 08, 2019	SELL	$35.49 - $43.02 $509,849 - $618,025	-14,366 Reduced 21.76%	51,664 $2.09 Million
Q4 2018 Feb 13, 2019	BUY	$36.86 - $41.49 $57,391 - $64,599	1,557 Added 2.41%	66,030 $2.51 Million
Q3 2018 Nov 01, 2018	SELL	$34.76 - $39.72 $590 - $675	-17 Reduced 0.03%	64,473 $2.55 Million
Q2 2018 Aug 08, 2018	SELL	$34.55 - $37.05 $197,695 - $212,000	-5,722 Reduced 8.15%	64,490 $2.26 Million
Q1 2018 May 08, 2018	BUY	$32.97 - $36.63 $186,313 - $206,996	5,651 Added 8.75%	70,212 $2.46 Million
Q4 2017 Feb 02, 2018	BUY	$32.09 - $34.78 $207,076 - $224,435	6,453 Added 11.11%	64,561 $2.24 Million
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $1.68 Million - $1.98 Million	58,108	58,108 $1.97 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account